-Solution Provides Physicians with CDC Treatment Guidelines at the Point of Care-
TAMPA, Fla., May 1 /PRNewswire/ -- Informed Decisions, LLC, a leading developer of drug information applications and clinical information solutions, announced today that its leading e-prescribing solution EMPOWERx is now providing physicians with the latest treatment guidelines for the H1N1 Influenza Virus as issued by the Centers for Disease Control and Prevention (CDC).
Due to the recent outbreak of H1N1 Influenza Virus Infection, also known as 'Swine Flu,' the CDC has provided additional guidance for certain medications used in the treatment of the condition. Information about these products and their impact has been updated and made available within EMPOWERx.
Trusted by more than 3500 physicians, EMPOWERx grants access to integrated drug information, drug-drug interaction screenings, real-time patient medication histories, up-to-date formulary information, a secure connection to submit scripts, and more. Physicians can have point-of-care access to this clinical drug reference, e-prescribing program and patient care system via wireless and cellular connectivity as well as the online secure EMPOWERx website.
"At Informed Decisions our goal is to arm physicians with the most current information at the point of care facilitating what we call fully informed prescribing. Whether it pertains to an individual's medication history, formulary updates, or medication guidelines for something as serious as the H1N1 Swine Flu, EMPOWERx is there to keep physicians informed and patients safe," said Kathy Mosbaugh, Executive Vice President, Informed Decisions.
About Informed Decisions, LLC
Informed Decisions (www.informeddecisions.com), an Elsevier company is based in Tampa, Fla. The company provides a full array of strategic health infor
|SOURCE Informed Decisions, LLC|
Copyright©2009 PR Newswire.
All rights reserved